Resource Logo
CDC HIV/AIDS/Viral Hepatitis/STD/TB Prevention News Update

SWITZERLAND: Scientists Reveal How Natural Antibiotic Kills Tuberculosis Bacterium




 

Medical Xpress (09.17.12) Aids Weekly Plus

Researchers in Switzerland have shown that pyridomycin, a natural antibiotic produced by the soil bacterium Dactylosporangium fulvum, may lead to the development of a new antituberculosis drug. According to Stewart Cole, lead author of the study, a member of the European Molecular Biology Organization (EMBO), and a professor at the École Polytechnique Fédérale de Lausanne in Switzerland, pyridomycin is a very selective killer of Mycobacterium tuberculosis. It is also active against bacteria resistant to isoniazid, a first-line drug for treating TB. The researchers identified a protein called InhA, as the target of the antibiotic. The gene InhA is necessary for producing the InhA protein, which is also a target for the TB drug isoniazid. Pyridomycin binds to a different site on the InhA enzyme than isoniazid. Using live bacteria, the researchers showed that pyridomycin led to depletion of mycolic acids. These are fatty acids that are an essential to the component of the bacterial cell wall. Cole noted that the finding that pyridomycin kills the TB bacterium by inhibiting InhA, even in bacteria resistant to the drug isoniazid, means that there is a possibility of developing pyridomycin or a related agent as treatment for drug-resistant TB. [PNU Editor’s note: The study, “Towards a New Tuberculosis Drug: Pyridomycin – Nature's Isoniazid,” was published ahead of the print version of EMBO Molecular Medicine [17 September 2012; DOI: 0.1002/emmm.201201689])



 


Copyright © 2012 -CDC Prevention News Update, Publisher. All rights reserved to Information, Inc., Bethesda, MD. The CDC National Center for HIV, STD and TB Prevention provides the following information as a public service only. Providing synopses of key scientific articles and lay media reports on HIV/AIDS, other sexually transmitted diseases and tuberculosis does not constitute CDC endorsement. This daily update also includes information from CDC and other government agencies, such as background on Morbidity and Mortality Weekly Report (MMWR) articles, fact sheets, press releases and announcements. Reproduction of this text is encouraged; however, copies may not be sold, and the CDC HIV/STD/TB Prevention News Update should be cited as the source of the information. Contact the sources of the articles abstracted below for full texts of the articles.



Information in this article was accurate in September 19, 2012. The state of the art may have changed since the publication date. This material is designed to support, not replace, the relationship that exists between you and your doctor. Always discuss treatment options with a doctor who specializes in treating HIV.